Open Your FREE Demat Account Now!

Apply Now

N/A

indicator

Nifty Pharma

1D

1M

3M

6M

1Y

5Y

empty graph

Previous Close	₹25,823.25
Day's Range	₹25,657.65 - ₹26,035.25
Open	₹25,855.30
52 Week Range	₹21,149.90 - ₹27,255.05
Volume	2,32,63,073

Nifty Pharma Companies

Company Name	LTP (₹)	Change (₹)	Sector
Cipla Ltd.	1301.00	-5.80 (-0.44%)	Healthcare
Dr. Reddy's Laboratories Ltd.	1197.00	17.00 (1.44%)	Healthcare
Lupin Ltd.	1956.50	19.60 (1.01%)	Healthcare
Torrent Pharmaceuticals Ltd.	4656.90	39.80 (0.86%)	Healthcare
Abbott India Ltd.	26000.00	420.00 (1.64%)	Healthcare
Ipca Laboratories Ltd.	1915.40	-23.00 (-1.19%)	Healthcare
Sun Pharmaceutical Industries Ltd.	1760.00	0.20 (0.01%)	Healthcare
Aurobindo Pharma Ltd.	1693.00	48.00 (2.92%)	Healthcare
Glenmark Pharmaceuticals Ltd.	2293.00	100.80 (4.60%)	Healthcare
Wockhardt Ltd.	1996.40	-33.20 (-1.64%)	Healthcare

All Indices

NSE BSE

Index Name	Market Value	52W High	52W Low
Nifty 50	22520.45	26373.20	22179.90
Nifty IT	28574.9	40301.40	25699.10
Nifty Next 50	68166.7	75000.40	59896.10
NIFTY50 USD Index	8068.1	10443.40	7839.85
Nifty Bank	55256.65	61764.85	49954.85
NIFTY Midcap 100	58787.3	64450.90	52032.85
Nifty 500	21866.65	24144.20	20385.65
Nifty Midcap 50	16786.7	18500.95	14804.55
Nifty 100	23547.9	26975.15	22720.45
Nifty FMCG	44864.25	57445.20	43442.30

Latest News

Oct

9

2026

EQUITY Posted on Oct 9^th 2026

Torrent Pharmaceuticals submits analyst meet intimation

Torrent Pharmaceuticals has informed that the Company has scheduled a teleconference with Investors/ Analysts on 23rd October, 2026 at 05:30 PM to discuss the financial performance of the Company for the quarter and half year ended 30th September, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

9

2026

EQUITY Posted on Oct 9^th 2026

Aurobindo Pharma informs about newspaper publication

Aurobindo Pharma has enclosed the copies of notice published by the Company on October 9, 2026, in Business Standard and Nava Telangana (Telugu) regarding special window for re-lodgement of transfer requests of physical shares.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

6

2026

EQUITY Posted on Oct 6^th 2026

Lupin informs about press release

Lupin has informed that it enclosed a Press Release titled ‘Lupin Launches Formoflo-G® MDI, World’s First Fixed-dose Triple Combination Drug for COPD Management’.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

6

2026

EQUITY Posted on Oct 6^th 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Adapalene Gel USP, 0.1% (OTC) in new pump packs. Glenmark’s Adapalene Gel USP, 0.1% can be compared to the active ingredient of Differin®2 Gel, 0.1%. According to Nielsen® syndicated data for the latest 52-week period ending September 5, 2026, the Differin® Gel, 0.1% (OTC) market3 achieved annual sales of approximately $45.8 million*. The company has attached media release in this regard.

The above information is a part of company’s filings submitted to BSE.

Read More

Oct

3

2026

EQUITY Posted on Oct 3^rd 2026

Aurobindo Pharma informs about acquisition

Aurobindo Pharma has informed that this is with refer to letters dated July 23, 2026, September 12, 2026 and October 01, 2026, informing that Apitoria Pharma Private Limited (Apitoria), a wholly owned subsidiary of the Company, is acquiring the Contract Research Services business of A1 Biochem Group. A1 Biochem USA Inc (A1 USA Inc), which is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited (A1 Labs India), has acquired 100% ownership of A1 Biochem Labs LLC (A1 Labs LLC) in accordance with the terms of the Definitive Agreements entered into for the acquisition of A1 Biochem Group. A1 Labs LLC is operating from USA and will now be a step-down subsidiary of A1 Labs India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Read More

STEP 1/2

Open Demat Account today!

Mobile Number

Enter mobile number

Frequently Asked Questions

What is the Previous Close of NIFTYPHARMA index?

The previous close of NIFTYPHARMA index is ₹25962.05 as of 2026-10-09.

What is the total Volume of NIFTYPHARMA index?

The total volume of NIFTYPHARMA index is 23261746.00 as of 2026-10-09.

What is the percentage change in value of NIFTYPHARMA index?

The percentage change in value of NIFTYPHARMA index is 0.54% as of 2026-10-09.

What is the absolute increase in index value since the previous trading day of NIFTYPHARMA index?

The absolute increase in NIFTYPHARMA index value since the previous trading day is ₹138.8 as of 2026-10-09.

What is the significance of a stock reaching its 52-week high?

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More

People Also Ask

What is the Nifty Pharma Index?

The Nifty Pharma Index is a sectoral stock market index that represents the performance of leading pharmaceutical companies listed on the National Stock Exchange (NSE). It serves as a benchmark for tracking the Indian pharmaceutical sector.

What does the Nifty Pharma Index track?

The Nifty Pharma Index tracks the price performance of companies operating in the pharmaceutical industry. It helps market participants understand overall trends in the pharmaceutical sector and the movement of the index.

What is the index symbol of the Nifty Pharma Index?

The index symbol commonly used for the Nifty Pharma Index is NIFTY PHARMA.

How is the Nifty Pharma Index calculated?

The Nifty Pharma Index is calculated using the free-float market capitalisation method. This method considers only the shares that are readily available for trading in the market, helping reflect the investable value of the constituent companies.

How is the Nifty Pharma Index different from the Nifty 500?

The Nifty Pharma Index focuses only on pharmaceutical sector companies, while the Nifty 500 covers companies from multiple sectors across the Indian economy. As a result, the Nifty Pharma Index provides sector-specific exposure, whereas the Nifty 500 offers broader market representation.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.

STEP 1/2

Open a Demat Account today!

Mobile Number Enter Valid Mobile Number

Indices : Nifty 50 Nifty Bank Nifty Financial Services Nifty Next 50 Nifty Midcap 100 BSE Sensex India Vix

Stocks : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Home

Shopping

Loan Offers

My Accounts

Explore